Skip to main content

Find Clinical Trials

Home
Conditions
NPM1-mutant Refractory or Relapsed AML

Clinical trial condition

NPM1-mutant Refractory or Relapsed AML

Explore clinical trials studying NPM1-mutant Refractory or Relapsed AML. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

NPM1-mutant Refractory or Relapsed AML trial results

Not Yet Recruiting

Ziftomenib + Mezigdomide in Adolesc. and Adults w/ R/R AML

NCT07355335

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, KMT2A-rearranged, +6 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details